---

$0.74

-0.0560 ( -7.00% ) 223.9K

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2025-08-13	Buy	11766.00	Locklear Lisa
2025-08-13	Buy	11766.00	Baluch Khoso
2024-08-07	Sale	-16000.00	Motwani Neha J.
2024-08-07	Sale	-16000.00	Hajjar Roger Joseph
2024-07-03	Sale	-357.00	Locklear Lisa
2024-06-11	Sale	-125.00	Baluch Khoso
2024-06-07	Sale	-325.00	Lehr Paul T
2024-05-14	Sale	-16000.00	Kender Richard N
2024-05-06	Sale	-308.00	Agafonova Nataliya
2024-05-06	Sale	-410.00	Locklear Lisa